GlaxoSmithKline S.A.E reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was EGP 406.52 million compared to EGP 483.62 million a year ago. Net income was EGP 48.94 million compared to net loss of EGP 14.56 million a year ago. Basic earnings per share from continuing operations was EGP 0.59 compared to basic loss per share from continuing operations of EGP 0.17 a year ago. For the nine months, sales was EGP 1,161.86 million compared to EGP 1,425.39 million a year ago. Net income was EGP 70.14 million compared to EGP 101.4 million a year ago. Basic earnings per share from continuing operations was EGP 0.84 compared to EGP 1.21 a year ago.